Answers are grounded in this paper and cite their sources.
Article1 August 1956CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA: A DISEASE OF SMOKERSFRANCIS C. LOWELL, M.D., F.A.C.P., WILLIAM FRANKLIN, M.D., ALAN L. MICHELSON, M.D., IRVING W. SCHILLER, M.D.FRANCIS C. LOWELL, M.D., F.A.C.P.Search for more papers by this author, WILLIAM FRANKLIN, M.D.Search for more papers by this author, ALAN L. MICHELSON, M.D.Search for more papers by this author, IRVING W. SCHILLER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-45-2-268 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDuring the last two years a number of patients with chronic obstructive emphysema have been observed while under treatment with bronchodilator agents and the adrenal steroids, in the course of which our attention was drawn to an association between pulmonary emphysema, peptic ulcer, carcinoma of the lung and a high incidence of smoking. The association between emphysema and smoking was so striking that we postulated that smoking is the major factor in the pathogenesis of emphysema in this area.1 The present report is a detailed analysis of the data on which this opinion was based.It was only after we...Bibliography1. LowellFranklinMichelsonSchiller FCWALIW: A note on the association of emphysema, peptic ulcer and smoking, New England J. Med. 254: 123-124, (Jan. 19) 1956. CrossrefMedlineGoogle Scholar2. AbbottHopkinsVan FleetRobinson OAWAWEJS: A new approach to pulmonary emphysema, Thorax 8: 116, 1953. CrossrefMedlineGoogle Scholar3. PhillipsPhillipsPaullPecora RWAMAMDV: Chronic bronchitis—a neglected disease entity, Dis. of Chest 26: 520, 1954. CrossrefMedlineGoogle Scholar4. FranklinMichelsonLowellSchiller WALFCIW: The clinical value of a tracing of forced expiration (expirogram), I. Pulmonary disease, New England J. Med. 253: 799, 1955. CrossrefMedlineGoogle Scholar5. BaldwinCournandRichards EdADW: Pulmonary insufficiency; physiological classification, clinical methods of analysis, standard values in normal subjects, Medicine 27: 243-278, 1948. CrossrefMedlineGoogle Scholar6. HammondHorn ECD: The relationship between human smoking habits and death rates, J. A. M. A. 155: 1316, 1954. CrossrefMedlineGoogle Scholar7. Spain DM: Pathogenetic concepts of some aspects of pulmonary disease, Am. J. Surg. 89: 118, 1955. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Received for publication March 9, 1956.From the Evans Memorial and the Massachusetts Memorial Hospitals, and the Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.Requests for reprints should be addressed to Francis C. Lowell, M.D., Evans Memorial Hospital, 65 East Newton St., Boston, Mass. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMulti-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventionsInterstitial Lung Abnormalities, Emphysema, and Spirometry in SmokersThe difference in risk of chronic pulmonary disease morbidity and mortality between former elite athletes and ordinary men in FinlandBoth Duration and Pack-Years of Tobacco Smoking Should Be Used for Clinical Practice and ResearchHerbal Medication, Macmoondong Decoction, Attenuates LPS-Induced COPD in Small Airways via TGF- β , CCL-2, and CXCL1Socheongryongtang suppresses COPD-related changes in the pulmonary system through both cytokines and chemokines in a LPS COPD modelSputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyCardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling StudyAnxiety and Depression in COPD PatientsLung microbiome dynamics in COPD exacerbationsThe Neutrophil in Chronic Obstructive Pulmonary Disease. Too Little, Too Late or Too Much, Too Soon?Increased levels of soluble ICAM-1 in chronic obstructive pulmonary disease and resistant smokers are related to active smokingThe Lung Tissue Microbiome in Chronic Obstructive Pulmonary DiseaseChronic obstructive pulmonary disease and lung cancer: inflammation, the missing linkCYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50 000 individualsMAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine productionThe effect of female tobacco smoking on IVF outcomesMechanisms of chronic airway obstruction in smokersProposal for a New Theory of Molecular Transport Across Membranes: Implications for Lung Gas TransferenceCytology of Respiratory Epithelium as a Predictor of Respiratory Complications after OperationThe Variable Effect of Smoking on Pulmonary FunctionGenetic and Environmental Determinants of Chronic Obstructive Pulmonary DiseaseROGER K. LARSON, M.D., F.A.C.P., MARTIN L. BARMAN, M.D., FRIEDRICH KUEPPERS, M.D., H. HUGH FUDENBERG, M.D.Surfactant in Chronic SmokersMODERN CONCEPTS IN THE MANAGEMENT OF EMPHYSEMA IN THE AGED AND INFIRMA Contribution to the Epidemiology of Chronic BronchitisThe Familial Occurrence of Chronic Obstructive Pulmonary DiseaseROGER K. LARSON, M.D., F.A.C.P., MARTIN L. BARMAN, M.D.Tobacco and Respiratory DiseaseSmoking and the Health of Older MenTHE DIFFUSE OBSTRUCTIVE PULMONARY SYNDROME IN A TUBERCULOSIS SANATORIUM. I. ETIOLOGIC FACTORS*†W. Y. HALLETT, M.D., C. J. MARTIN, M.D., F.A.C.P.UNRECOGNIZED AIRWAY OBSTRUCTION ASSOCIATED WITH SMOKING: A PROBABLE FORERUNNER OF OBSTRUCTIVE PULMONARY EMPHYSEMA*†WILLIAM FRANKLIN, M.D., FRANCIS C. LOWELL, M.D., F.A.C.P.Krankheiten durch TabakrauchenTHE BROADMINDED SPECIALISTSMOKING AND "CHRONIC BRONCHITIS" IN THE U.S.A.LUNG VOLUME IN SMOKERS AND NONSMOKERS*†HENRY BLACKBURN, M.D., JOSEF BROŽEK, Ph.D., HENRY L. TAYLOR, Ph.D.A Study of Illness in a Group of Cleveland FamiliesA clinico-pathologic study of Cor pulmonale with heart failure∗Bronchodilators and Corticosteroids in the Treatment of Obstructive Pulmonary EmphysemaDiffuse Obstructive Pulmonary Emphysema, a Poorly Understood DisorderTHE IRRITATIVE EFFECT OF SMOKING ON THE RESPIRATORY MUCOUS MEMBRANESPAUL W. CLOUGHCODING FOR CASE-NOTESSMOKING AND BRONCHITIS 1 August 1956Volume 45, Issue 2Page: 268-274KeywordsChronic obstructive pulmonary diseaseDyspneaEmphysemaHospital medicineLung and intrathoracic tumorsPathogenesisPeptic ulcersPulmonary diseasesRespiratory system proceduresSteroids ePublished: 1 December 2008 Issue Published: 1 August 1956 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Michelson et al. (1956) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: